Cite
[The 12th amendment to the German Drug Law. Chances and obstacles for investigator-initiated clinical trials]
MLA
G, Dreier, et al. “[The 12th Amendment to the German Drug Law. Chances and Obstacles for Investigator-Initiated Clinical Trials].” Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, vol. 48, no. 4, Apr. 2005. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........3a630247c65db965743a17f01f767961&authtype=sso&custid=ns315887.
APA
G, D., C, M., C, S., & H, M.-L. (2005). [The 12th amendment to the German Drug Law. Chances and obstacles for investigator-initiated clinical trials]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 48(4).
Chicago
G, Dreier, Marx C, Schmoor C, and Maier-Lenz H. 2005. “[The 12th Amendment to the German Drug Law. Chances and Obstacles for Investigator-Initiated Clinical Trials].” Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 48 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........3a630247c65db965743a17f01f767961&authtype=sso&custid=ns315887.